Burcon Nutrascience (BRCNF) Ratios
Burcon Nutrascience Ratios
BRCNF's free cash flow for Q1 2027 was $-2.43M. For the 2027 fiscal year, BRCNF's free cash flow was decreased by $-57.07K and operating cash flow was $-2.37M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.19 | 1.82 | 3.83 | 2.98 | 7.30 |
| Quick Ratio | 0.15 | 1.77 | 3.78 | 2.98 | 7.30 |
| Cash Ratio | 0.07 | 1.69 | 3.10 | 2.33 | 6.71 |
| Solvency Ratio | -0.44 | -0.34 | -0.87 | -4.29 | -9.06 |
| Operating Cash Flow Ratio | -0.70 | -1.28 | -4.27 | -9.62 | -5.67 |
| Short-Term Operating Cash Flow Coverage | -1.07 | -2.64 | -22.15 | -174.71 | 11328.55 |
| Net Current Asset Value | $ -26.37M | $ -15.91M | $ -2.57M | $ -3.90M | $ 6.51M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.06 | 0.73 | 0.52 | 0.52 | 0.00 |
| Debt-to-Equity Ratio | -4.21 | 3.23 | 1.29 | 1.25 | 0.00 |
| Debt-to-Capital Ratio | 1.31 | 0.76 | 0.56 | 0.56 | 0.00 |
| Long-Term Debt-to-Capital Ratio | -0.04 | 0.45 | 0.55 | 0.55 | 0.00 |
| Financial Leverage Ratio | -3.97 | 4.42 | 2.51 | 2.39 | 1.04 |
| Debt Service Coverage Ratio | -0.79 | -2.70 | -8.07 | -56.64 | -87.86 |
| Interest Coverage Ratio | -3.40 | -11.51 | -14.62 | -25.14 | -65.19 |
| Debt to Market Cap | 0.37 | 0.53 | 0.00 | 0.00 | -0.00 |
| Interest Debt Per Share | 2.19 | 2.95 | 0.03 | 0.03 | 0.00 |
| Net Debt to EBITDA | -2.38 | -2.03 | -0.40 | -0.20 | 0.70 |
| Profitability Margins | |||||
| Gross Profit Margin | -354.16% | -228.31% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -506.14% | -2018.75% | -3761.47% | -5376.29% | -5940.29% |
| EBITDA Margin | -434.95% | -1949.33% | -3380.05% | -5194.65% | -5787.84% |
| Operating Profit Margin | -506.14% | -2018.75% | -4055.64% | -2067.88% | -4314.19% |
| Pretax Profit Margin | -646.60% | -2166.98% | -4038.96% | -6969.87% | -5982.59% |
| Net Profit Margin | -629.38% | -2166.98% | -4038.96% | -6969.87% | -5982.59% |
| Continuous Operations Profit Margin | -629.38% | -2166.98% | -4038.96% | -6969.87% | -5982.59% |
| Net Income Per EBT | 97.34% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 127.75% | 107.34% | 99.59% | 337.05% | 138.67% |
| Return on Assets (ROA) | -61.99% | -26.96% | -57.67% | -256.22% | -34.95% |
| Return on Equity (ROE) | 245.82% | -119.03% | -144.49% | -613.06% | -36.32% |
| Return on Capital Employed (ROCE) | -114.85% | -29.20% | -64.69% | -81.14% | -26.13% |
| Return on Invested Capital (ROIC) | -53.53% | -26.24% | -61.90% | -80.55% | -26.12% |
| Return on Tangible Assets | -82.84% | -28.11% | -63.87% | -890.35% | -46.89% |
| Earnings Yield | -60.71% | -55.63% | -0.53% | -2.16% | -0.20% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.22 | 3.48 | 1.37 | 1.10 | 0.86 |
| Payables Turnover | 4.96 | 0.98 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 19.49 | 6.23 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.16 | 0.02 | 0.17 | 0.37 | 0.20 |
| Asset Turnover | 0.10 | 0.01 | 0.01 | 0.04 | 0.01 |
| Working Capital Turnover Ratio | -0.64 | 0.10 | 0.07 | 0.09 | 0.02 |
| Cash Conversion Cycle | 58.34 | -207.12 | 266.50 | 333.11 | 426.46 |
| Days of Sales Outstanding | 113.22 | 104.96 | 266.50 | 333.11 | 426.46 |
| Days of Inventory Outstanding | 18.73 | 58.63 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 73.61 | 370.71 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 131.95 | 163.59 | 266.50 | 333.11 | 426.46 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.72 | -0.71 | -0.02 | -0.03 | -0.03 |
| Free Cash Flow Per Share | -0.80 | -0.74 | -0.02 | -0.03 | -0.03 |
| Dividend Paid and CapEx Coverage Ratio | -9.58 | -18.17 | -45.45 | -16.71 | -4.66 |
| Capital Expenditure Coverage Ratio | -9.58 | -18.17 | -45.45 | -16.71 | -4.66 |
| Operating Cash Flow Coverage Ratio | -0.38 | -0.25 | -0.87 | -1.16 | -80.85 |
| Operating Cash Flow to Sales Ratio | -4.05 | -14.45 | -31.34 | -16.53 | -34.49 |
| Free Cash Flow Yield | -43.11% | -39.15% | -0.42% | -0.54% | -0.14% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1.65 | -1.79 | -189.12 | -46.30 | -503.86 |
| Price-to-Sales (P/S) Ratio | 10.37 | 38.96 | 7638.57 | 3226.80 | 30143.81 |
| Price-to-Book (P/B) Ratio | -4.05 | 2.14 | 273.26 | 283.83 | 182.98 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.32 | -2.55 | -238.52 | -184.19 | -719.68 |
| Price-to-Operating Cash Flow Ratio | -2.56 | -2.70 | -243.77 | -195.21 | -874.07 |
| Price-to-Earnings Growth (PEG) Ratio | -0.29 | -0.00 | 2.62 | -0.35 | -0.34 |
| Enterprise Value Multiple | -4.77 | -4.03 | -226.39 | -62.31 | -520.11 |
| Enterprise Value | 46.94M | 29.98M | 1.41B | 1.18B | 5.16B |
| EV to EBITDA | -4.77 | -4.03 | -226.39 | -62.31 | -520.11 |
| EV to Sales | 20.73 | 78.60 | 7651.96 | 3237.00 | 30103.41 |
| EV to Free Cash Flow | -4.64 | -5.15 | -238.94 | -184.77 | -718.71 |
| EV to Operating Cash Flow | -5.12 | -5.44 | -244.19 | -195.82 | -872.89 |
| Tangible Book Value Per Share | -0.91 | 0.73 | 0.02 | -0.01 | 0.10 |
| Shareholders’ Equity Per Share | -0.46 | 0.89 | 0.02 | 0.02 | 0.13 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.18 | 0.05 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.12 | -1.06 | -0.03 | -0.12 | -0.05 |
| Tax Burden | 0.97 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.28 | 1.07 | 1.07 | 1.30 | 1.01 |
| Research & Development to Revenue | 0.46 | 9.11 | 18.22 | 11.34 | 19.21 |
| SG&A to Revenue | 1.27 | 10.24 | 19.66 | 10.26 | 24.48 |
| Stock-Based Compensation to Revenue | 0.24 | 1.95 | 4.40 | 3.45 | 8.37 |
| Income Quality | 0.64 | 0.67 | 0.78 | 0.24 | 0.58 |
Currency in CAD